Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jul;29(7):638-639.
doi: 10.1111/iju.14883. Epub 2022 Mar 31.

Editorial Comment from Dr Naselli and Dr Pirola to Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study)

Affiliations
Editorial

Editorial Comment from Dr Naselli and Dr Pirola to Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study)

Angelo Naselli et al. Int J Urol. 2022 Jul.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Kobayashi K, Matsuyama H, Kawai T et al. Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study). Int. J. Urol. 2022; 29: 632-8.
    1. Ieda T, Muto S, Shimizu F et al. Development and validation of a novel recurrence risk stratification for initial non-muscle invasive bladder cancer in Asia. EBioMedicine 2016; 12: 98-104.
    1. Soukup V, Čapoun O, Cohen D et al. Risk stratification tools and prognostic models in non-muscle-invasive bladder cancer: a critical assessment from the European Association of Urology non-muscle-invasive bladder cancer guidelines panel. Eur. Urol. Focus 2020; 6: 479-89.
    1. Maisch P, Koziarz A, Vajgrt J et al. Blue versus white light for transurethral resection of non-muscle invasive bladder cancer. Cochrane Database Syst. Rev. 2021; 12: CD013776.
    1. Witjes JA, Babjuk M, Gontero P et al. Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendations. Eur. Urol. 2014; 66: 863-71.

LinkOut - more resources